WGU D027 Advanced Pathopharmacological
Foundations OA Exam ACTUAL EXAM 2026/2027 |
Complete Exam-Style Q&A | Verified Q&A | Pass
Guaranteed - A+ Graded
Table of Contents
Section 1: Cellular & Immunologic Foundations (Questions 1–15) ...... 2
Section 2: Cardiovascular & Respiratory Pathophysiology & Pharmacology (Questions 16–30) ...... 2
Section 3: Neurological & Endocrine Pathophysiology & Pharmacology (Questions 31–45) ...... 2
Section 4: Renal, GI, & Hepatic Pathophysiology & Pharmacology (Questions 46–55) ...... 2
Section 5: Hematologic, Musculoskeletal, & Reproductive Pathophysiology & Pharmacology (Questions
56–70) ...... 2
Section 1: Cellular & Immunologic Foundations
Q1: A patient develops a type I hypersensitivity reaction after exposure to penicillin. The primary
immune mediator responsible for the immediate symptoms is:
A. IgG antibodies
B. IgM antibodies
C. IgE antibodies. [CORRECT]
D. IgA antibodies
Correct Answer: C
Rationale: Type I hypersensitivity reactions are mediated by IgE antibodies, which bind to mast cells and
basophils. Upon re-exposure to the allergen, cross-linking of IgE triggers degranulation, releasing
histamine, leukotrienes, and prostaglandins, producing immediate symptoms such as urticaria,
bronchospasm, and anaphylaxis.
Q2: A patient with systemic lupus erythematosus (SLE) presents with joint pain, photosensitivity, and a
positive ANA. The underlying pathophysiological mechanism is:
A. Bacterial infection of connective tissue
B. Autoimmune-mediated destruction of self-tissues by autoantibodies and immune complex
deposition. [CORRECT]
,C. Viral infiltration of skin and joints
D. Malignant transformation of lymphocytes
Correct Answer: B
Rationale: SLE is a systemic autoimmune disease characterized by the production of autoantibodies,
particularly antinuclear antibodies (ANA), and the formation of immune complexes that deposit in
tissues, activating complement and causing inflammation. This immune complex deposition in joints,
skin, kidneys, and other organs produces the multi-system clinical manifestations of SLE.
Q3: A tumor suppressor gene that normally regulates the cell cycle and promotes apoptosis when DNA
damage is detected is:
A. BRCA1
B. p53. [CORRECT]
C. HER2
D. BCL-2
Correct Answer: B
Rationale: The p53 gene, often called the "guardian of the genome," is a critical tumor suppressor that
functions as a transcription factor. When DNA damage is detected, p53 arrests the cell cycle at the G1
checkpoint to allow repair or initiates apoptosis if damage is irreparable. Mutations in p53 are among
the most common genetic alterations in human cancers.
Q4: A patient with chronic inflammation exhibits elevated levels of C-reactive protein (CRP) and
erythrocyte sedimentation rate (ESR). These markers reflect:
A. Direct bacterial infection
B. Acute-phase response mediated by IL-6 and other pro-inflammatory cytokines. [CORRECT]
C. Autoimmune antibody production
D. Malignant cell proliferation
Correct Answer: B
Rationale: CRP and ESR are acute-phase reactants produced by the liver in response to pro-
inflammatory cytokines, particularly interleukin-6 (IL-6), released during the inflammatory response.
These markers indicate ongoing systemic inflammation but are non-specific and do not identify the
underlying cause, which may be infectious, autoimmune, or neoplastic.
Q5: In the clotting cascade, tissue factor (Factor III) initiates the:
, A. Intrinsic pathway
B. Extrinsic pathway. [CORRECT]
C. Common pathway
D. Fibrinolytic pathway
Correct Answer: B
Rationale: The extrinsic pathway of coagulation is initiated when tissue factor (Factor III), exposed by
vascular injury, binds to Factor VIIa. This complex activates Factor X, leading to the common pathway
and ultimately fibrin formation. The intrinsic pathway is initiated by contact activation, while the
common pathway is where intrinsic and extrinsic pathways converge.
Q6: A patient with rheumatoid arthritis has elevated levels of rheumatoid factor (RF) and anti-CCP
antibodies. These antibodies primarily target:
A. Synovial fluid proteins
B. The Fc portion of IgG antibodies. [CORRECT]
C. Cartilage collagen
D. Bone matrix proteins
Correct Answer: B
Rationale: Rheumatoid factor is an autoantibody directed against the Fc portion of IgG antibodies,
forming immune complexes that deposit in joints and activate complement, perpetuating inflammation.
Anti-cyclic citrullinated peptide (anti-CCP) antibodies target citrullinated proteins and are highly specific
for rheumatoid arthritis, often present before clinical symptoms develop.
Q7: A patient develops acute cellular rejection of a kidney transplant. The primary immune cells
responsible for attacking the graft are:
A. B lymphocytes
B. CD8+ cytotoxic T lymphocytes. [CORRECT]
C. Eosinophils
D. Neutrophils
Correct Answer: B
Rationale: Acute cellular rejection is primarily mediated by CD8+ cytotoxic T lymphocytes that recognize
donor MHC class I antigens on graft cells and directly kill them through perforin/granzyme-mediated
cytotoxicity and Fas-Fas ligand interactions. CD4+ T helper cells also contribute by recruiting and
activating other immune cells. B cells and antibodies play a role in humoral rejection.
Foundations OA Exam ACTUAL EXAM 2026/2027 |
Complete Exam-Style Q&A | Verified Q&A | Pass
Guaranteed - A+ Graded
Table of Contents
Section 1: Cellular & Immunologic Foundations (Questions 1–15) ...... 2
Section 2: Cardiovascular & Respiratory Pathophysiology & Pharmacology (Questions 16–30) ...... 2
Section 3: Neurological & Endocrine Pathophysiology & Pharmacology (Questions 31–45) ...... 2
Section 4: Renal, GI, & Hepatic Pathophysiology & Pharmacology (Questions 46–55) ...... 2
Section 5: Hematologic, Musculoskeletal, & Reproductive Pathophysiology & Pharmacology (Questions
56–70) ...... 2
Section 1: Cellular & Immunologic Foundations
Q1: A patient develops a type I hypersensitivity reaction after exposure to penicillin. The primary
immune mediator responsible for the immediate symptoms is:
A. IgG antibodies
B. IgM antibodies
C. IgE antibodies. [CORRECT]
D. IgA antibodies
Correct Answer: C
Rationale: Type I hypersensitivity reactions are mediated by IgE antibodies, which bind to mast cells and
basophils. Upon re-exposure to the allergen, cross-linking of IgE triggers degranulation, releasing
histamine, leukotrienes, and prostaglandins, producing immediate symptoms such as urticaria,
bronchospasm, and anaphylaxis.
Q2: A patient with systemic lupus erythematosus (SLE) presents with joint pain, photosensitivity, and a
positive ANA. The underlying pathophysiological mechanism is:
A. Bacterial infection of connective tissue
B. Autoimmune-mediated destruction of self-tissues by autoantibodies and immune complex
deposition. [CORRECT]
,C. Viral infiltration of skin and joints
D. Malignant transformation of lymphocytes
Correct Answer: B
Rationale: SLE is a systemic autoimmune disease characterized by the production of autoantibodies,
particularly antinuclear antibodies (ANA), and the formation of immune complexes that deposit in
tissues, activating complement and causing inflammation. This immune complex deposition in joints,
skin, kidneys, and other organs produces the multi-system clinical manifestations of SLE.
Q3: A tumor suppressor gene that normally regulates the cell cycle and promotes apoptosis when DNA
damage is detected is:
A. BRCA1
B. p53. [CORRECT]
C. HER2
D. BCL-2
Correct Answer: B
Rationale: The p53 gene, often called the "guardian of the genome," is a critical tumor suppressor that
functions as a transcription factor. When DNA damage is detected, p53 arrests the cell cycle at the G1
checkpoint to allow repair or initiates apoptosis if damage is irreparable. Mutations in p53 are among
the most common genetic alterations in human cancers.
Q4: A patient with chronic inflammation exhibits elevated levels of C-reactive protein (CRP) and
erythrocyte sedimentation rate (ESR). These markers reflect:
A. Direct bacterial infection
B. Acute-phase response mediated by IL-6 and other pro-inflammatory cytokines. [CORRECT]
C. Autoimmune antibody production
D. Malignant cell proliferation
Correct Answer: B
Rationale: CRP and ESR are acute-phase reactants produced by the liver in response to pro-
inflammatory cytokines, particularly interleukin-6 (IL-6), released during the inflammatory response.
These markers indicate ongoing systemic inflammation but are non-specific and do not identify the
underlying cause, which may be infectious, autoimmune, or neoplastic.
Q5: In the clotting cascade, tissue factor (Factor III) initiates the:
, A. Intrinsic pathway
B. Extrinsic pathway. [CORRECT]
C. Common pathway
D. Fibrinolytic pathway
Correct Answer: B
Rationale: The extrinsic pathway of coagulation is initiated when tissue factor (Factor III), exposed by
vascular injury, binds to Factor VIIa. This complex activates Factor X, leading to the common pathway
and ultimately fibrin formation. The intrinsic pathway is initiated by contact activation, while the
common pathway is where intrinsic and extrinsic pathways converge.
Q6: A patient with rheumatoid arthritis has elevated levels of rheumatoid factor (RF) and anti-CCP
antibodies. These antibodies primarily target:
A. Synovial fluid proteins
B. The Fc portion of IgG antibodies. [CORRECT]
C. Cartilage collagen
D. Bone matrix proteins
Correct Answer: B
Rationale: Rheumatoid factor is an autoantibody directed against the Fc portion of IgG antibodies,
forming immune complexes that deposit in joints and activate complement, perpetuating inflammation.
Anti-cyclic citrullinated peptide (anti-CCP) antibodies target citrullinated proteins and are highly specific
for rheumatoid arthritis, often present before clinical symptoms develop.
Q7: A patient develops acute cellular rejection of a kidney transplant. The primary immune cells
responsible for attacking the graft are:
A. B lymphocytes
B. CD8+ cytotoxic T lymphocytes. [CORRECT]
C. Eosinophils
D. Neutrophils
Correct Answer: B
Rationale: Acute cellular rejection is primarily mediated by CD8+ cytotoxic T lymphocytes that recognize
donor MHC class I antigens on graft cells and directly kill them through perforin/granzyme-mediated
cytotoxicity and Fas-Fas ligand interactions. CD4+ T helper cells also contribute by recruiting and
activating other immune cells. B cells and antibodies play a role in humoral rejection.
